A study of 136 patients diagnosed with schizophrenia and evaluating clinical improvement using the Positive and Negative Syndrome Scale (PANSS) did not showed association between CYP2D6 activity variations and clinical outcome [61]. This evidence concerns the gene CYP2D6 and schizophrenia.